ArticleBreast cancer research and treatment2013

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.

Sameer Mirza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.